Journal of Cancer Research and Clinical Oncology

, Volume 117, Issue 6, pp 603–607

Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas

  • P. Münzel
  • D. Marx
  • H. Köchel
  • A. Schauer
  • K. W. Bock
Original Papers Clinical Oncology

Summary

Genomic alterations of c-myc (amplification, rearrangements and hypomethylation) were investigated in 30 breast carcinomas and 20 cervix carcinomas. In breast carcinomas c-myc alterations were compared with overexpression of the c-erbB2 protooncogene and the proliferation marker Ki-67. Alterations of c-myc were found in 50% of the breast carcinomas and in 25% of the cervix carcinomas. In 23% of the breast carcinomas c-erbB2 overexpression was associated with c-myc alterations. In 17% of the cases there was overexpression of c-erbB2 without detectable alterations of c-myc. Hence, in 67% of breast cancers alterations of c-myc and/or c-erbB2 have been found, while in 81% of the samples Ki-67 expression was increased. The results suggest that the study of c-myc alterations provides an important complement to that of other prognostic indicators of breast cancer such as c-erbB2 expression.

Key words

c-myc- c-erbB2 Ki-67 Breast cancer Cervix cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alitalo K, Koskinen P, Mäkelä TP, Saksela K, Sistonen L, Winqvist R (1987) myc oncogenes: activation and amplification. Biochim Biophys Acta 907:1–32Google Scholar
  2. Bargmann CI, Hung M-C, Weinberg RA (1986) Theneu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226–230Google Scholar
  3. Berger MS, Locher GW, Saurer S, Gullik WJ, Waterfield MD, Groner B, Hynes NE (1988) Correlation of c-erb-B2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48:1238–1243Google Scholar
  4. Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311Google Scholar
  5. Bister K, Ramsay GM, Hayman MJ (1982) Deletions within the transformation-specific RNA sequences of acute leukemia virus MC29 give rise ro partially transformation-defective mutants. J Virol 41:754–766Google Scholar
  6. Blin N, Stafford DW (1976) A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3:2303–2308Google Scholar
  7. Boehm TLJ, Drahovsky D (1983) Alteration of enzymatic methylation of DNA cytosines by chemical carcinogens: a mechanism involved in the initiation of carcinogenesis. J Natl Cancer Inst 71:429–433Google Scholar
  8. Cheah MSC, Wallace CD, Hoffman RM (1984) Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J Natl Cancer Inst 73:1057–1065Google Scholar
  9. Escot C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest J, Callahan R (1986) Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 83:4834–4838Google Scholar
  10. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody Ki-67. Immunology 133:1710–1715Google Scholar
  11. Gomez-Pedrozo M, Mohandas T, Sparkes R, Shaw J-P, Hess JF, Ayres T, Shen CJ (1987) Evolution of human cytoplasmic actin gene sequences: chromosome mapping and structural characterizations of three cytoplasmic actin-like pseudogenes including one of the Y chromosome. J Hum Evol 16:215–230Google Scholar
  12. Leder P, Battey J, Lenoir G, Moulding C, Murphy W, Potter H, Stewart T, Taub R (1983) Translocations among antibody genes in human cancer. Science 222:765–771Google Scholar
  13. Macara IG (1989) Oncogenes and cellular signal transduction. Physiol Rev 69:797–820Google Scholar
  14. Mariani-Costantini R, Escot C, Theillet C, Gentile A, Merlo G, Lidereau R, Callahan R (1988) In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res 48:199–205Google Scholar
  15. Marx D, Schauer A, Reiche C, May A, Ummenhofer L, Reles A, Rauschecker H, Sauer R, Schumacher M (1990) c-erbB2 expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116:15–20Google Scholar
  16. Moos M, Gallwitz D (1983) Structure of two human β-actin related processed genes one of which is located next to a simple repetitive sequence. EMBO J 2:757–761Google Scholar
  17. Münzel P, Bock KW (1989) Hypomethylation of c-myc protooncogene ofN-nitrosomorpholine-induced rat liver nodules and of H4IIE cells. Arch Toxicol [Suppl] 13:211–213Google Scholar
  18. Münzel PA, Pfohl-Leskowicz A, Röhrdanz E, Keith G, Dirheimer G, Bock KW (1991) Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation byN-nitrosomorpholine. Biochem Pharmacol 42:365–371Google Scholar
  19. Ocadiz R, Sauceda R, Cruz M, Graef AM, Gariglio P (1987) High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res 47:4173–4177Google Scholar
  20. Parkin DM, Stjernswärd J, Muir CS (1984) Estimates of the worldwide frequency of twelve major cancers. Bull WHO 62:163Google Scholar
  21. Slamon DJ, deKernion JB, Verma IM, Cline MJ (1984) Expression of cellular oncogenes in human malignancies. Science 224:256–262Google Scholar
  22. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: Correlation of relapse and survival with amplification of theHER-2/neu oncogene. Science 235:177–182Google Scholar
  23. Studzinski GP, Brevli ZS, Feldman SC, Watt RA (1986) Participation of c-myc protein in DNA synthesis of human cells. Science 234:467–470Google Scholar
  24. Vijer MJ van de, Mooi WJ, Peterse JL, Nusse R (1988) Amplification and overexpression of the neu oncogene in human breast carcinomas. Eur J Surg Oncol 14:111–114Google Scholar
  25. Varmus HE (1984) The molecular genetics of cellular oncogenes. Annu Rev Genet 18:553–612Google Scholar
  26. Watson DK, Psallidopoulous MC, Samuel KP, Dalla-Favera R, Papas TS (1983) Nucleotide sequence analysis of human c-myc locus, chicken homologue and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product. Proc Natl Acad Sci USA 80:3642–3645Google Scholar
  27. Weinberg RA (1989) Oncogenes, antioncogenes and the molecular basis of multistep carcinogenesis. Cancer Res 49:3713–3721Google Scholar
  28. Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CHW (1989) Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 49:2087–2090Google Scholar
  29. Yamamoto T, Shantard I, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) An erb-B-related gene c-erbB-2 encodes a possible receptor protein similar to the epidermal growth factor receptor. Nature 319:230–234Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • P. Münzel
    • 1
  • D. Marx
    • 2
  • H. Köchel
    • 3
  • A. Schauer
    • 2
  • K. W. Bock
    • 1
  1. 1.Institute of ToxicologyUniversity of TübingenTübingenGermany
  2. 2.Institute of PathologyUniversity of GöttingenGöttingenGermany
  3. 3.Institute of Hygiene and MicrobiologyUniversity of GöttingenGöttingenGermany

Personalised recommendations